209 related articles for article (PubMed ID: 24235143)
1. Bone morphogenetic proteins signal via SMAD and mitogen-activated protein (MAP) kinase pathways at distinct times during osteoclastogenesis.
Broege A; Pham L; Jensen ED; Emery A; Huang TH; Stemig M; Beppu H; Petryk A; O'Connor M; Mansky K; Gopalakrishnan R
J Biol Chem; 2013 Dec; 288(52):37230-40. PubMed ID: 24235143
[TBL] [Abstract][Full Text] [Related]
2. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.
Omi M; Kaartinen V; Mishina Y
J Biol Chem; 2019 Nov; 294(47):17818-17836. PubMed ID: 31619522
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein-9 activates Smad and ERK pathways and supports human osteoclast function and survival in vitro.
Fong D; Bisson M; Laberge G; McManus S; Grenier G; Faucheux N; Roux S
Cell Signal; 2013 Apr; 25(4):717-28. PubMed ID: 23313128
[TBL] [Abstract][Full Text] [Related]
4. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
Li L; Sapkota M; Gao M; Choi H; Soh Y
Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027
[TBL] [Abstract][Full Text] [Related]
5. WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.
Chen C; Qin Y; Fang JP; Ni XY; Yao J; Wang HY; Ding K
Acta Pharmacol Sin; 2015 Sep; 36(9):1053-64. PubMed ID: 26299951
[TBL] [Abstract][Full Text] [Related]
6. Bone Morphogenetic Protein-2 Promotes Osteoclasts-mediated Osteolysis via Smad1 and p65 Signaling Pathways.
Miao X; Yuan J; Wu J; Zheng J; Zheng W; Wang F; Wang C; Li X; Liu S; Shi Z; Li J
Spine (Phila Pa 1976); 2021 Feb; 46(4):E234-E242. PubMed ID: 33156278
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.
Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H
Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors.
Jensen ED; Pham L; Billington CJ; Espe K; Carlson AE; Westendorf JJ; Petryk A; Gopalakrishnan R; Mansky K
J Cell Biochem; 2010 Mar; 109(4):672-82. PubMed ID: 20039313
[TBL] [Abstract][Full Text] [Related]
9. Enhancing effects of myricetin on the osteogenic differentiation of human periodontal ligament stem cells via BMP-2/Smad and ERK/JNK/p38 mitogen-activated protein kinase signaling pathway.
Kim HY; Park SY; Choung SY
Eur J Pharmacol; 2018 Sep; 834():84-91. PubMed ID: 30012495
[TBL] [Abstract][Full Text] [Related]
10. HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylation.
Wu X; Chim SM; Kuek V; Lim BS; Chow ST; Zhao J; Yang S; Rosen V; Tickner J; Xu J
FEBS Lett; 2014 Jan; 588(1):143-50. PubMed ID: 24269886
[TBL] [Abstract][Full Text] [Related]
11. [Osteoclast differentiation regulated by receptor activator of nuclear factor kappaB probably through a novel signaling pathway].
Xu DR; Chen HZ; Wang HH; Li J; Luo SK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):607-11. PubMed ID: 19549373
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 2 signaling in osteoclasts is negatively regulated by the BMP antagonist, twisted gastrulation.
Pham L; Beyer K; Jensen ED; Rodriguez JS; Davydova J; Yamamoto M; Petryk A; Gopalakrishnan R; Mansky KC
J Cell Biochem; 2011 Mar; 112(3):793-803. PubMed ID: 21328453
[TBL] [Abstract][Full Text] [Related]
13. BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity.
Jun JH; Yoon WJ; Seo SB; Woo KM; Kim GS; Ryoo HM; Baek JH
J Biol Chem; 2010 Nov; 285(47):36410-9. PubMed ID: 20851880
[TBL] [Abstract][Full Text] [Related]
14. Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression.
Ghosh-Choudhury N; Singha PK; Woodruff K; St Clair P; Bsoul S; Werner SL; Choudhury GG
J Biol Chem; 2006 Jul; 281(29):20160-70. PubMed ID: 16707491
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
17. Smad1/5 and Smad4 expression are important for osteoclast differentiation.
Tasca A; Stemig M; Broege A; Huang B; Davydova J; Zwijsen A; Umans L; Jensen ED; Gopalakrishnan R; Mansky KC
J Cell Biochem; 2015 Jul; 116(7):1350-60. PubMed ID: 25711193
[TBL] [Abstract][Full Text] [Related]
18. Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling.
Sotillo Rodriguez JE; Mansky KC; Jensen ED; Carlson AE; Schwarz T; Pham L; MacKenzie B; Prasad H; Rohrer MD; Petryk A; Gopalakrishnan R
J Bone Miner Res; 2009 Nov; 24(11):1917-26. PubMed ID: 19419314
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
20. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
